|
Sign In to gain access to subscriptions and/or personal tools.
|
Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test
B A Parmenter
B Weinstock-Guttman
N Garg
F Munschauer
R HB Benedict
Department of Neurology, Division of Developmental; Behavioral Neurosciences, State University of New York at Buffalo School of Medicine; Biomedical Sciences, Buffalo, NY, USA; Department of Psychology, State University of New York at Buffalo, Buffalo, NY, USA
Cognitive impairment is common in multiple sclerosis (MS), yet difficult to detect duringroutine neurologic examination. Therefore, briefscreening tests that identify patients who may benefit from a more thorough assessment or treatment are needed. We investigated the utility of the Symbol Digit Modalities Test (SDMT) as a screen for cognitive dysfunction because it can be administered and scored in about 5 minutes. One hundred MS patients and 50 healthy controls, matched on demographic variables, participated in the study. Examination procedures included the neuropsychological (NP) tests included in the Minimal Assessment of Cognitive Function in MS (MACFIMS) battery. Patients were considered impaired if they performed one and a half standard deviations below controls on two or more MACFIMS variables, excluding theSDMT. Bayesian statistics showed that a total score of 55 or lower onthe SDMT accurately categorized 72% of patients, yielding sensitivityof 0.82, specificity of 0.60, positive predictive value (PPV) of 0.71, and negative predictive value (NPV) of 0.73. These results suggest that the effectiveness of the SDMT as a screen for cognitive impairment in MS is roughly equal to that of other psychometric and questionnaire methods.
Key Words: cognition neuropsychology processing speed psychological speed screening
Multiple Sclerosis, Vol. 13, No. 1,
52-57 (2007)
DOI: 10.1177/1352458506070750

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. K Coyle, J. F Foley, E. J Fox, D. R Jeffery, F. E Munschauer III, and C. Tornatore
Best practice recommendations for the selection and management of patients with multiple sclerosis receiving natalizumab therapy
Multiple Sclerosis,
November 1, 2009;
15(4_suppl):
S26 - S36.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. van der Walt, J. Stankovich, M. Bahlo, B. V. Taylor, I.A.F. van der Mei, S. J. Foote, T. J. Kilpatrick, J. P. Rubio, and H. Butzkueven
Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy
Neurology,
September 29, 2009;
73(13):
1018 - 1025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Ukkonen, T Vahvelainen, P Hamalainen, P Dastidar, and I Elovaara
Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study
Multiple Sclerosis,
September 1, 2009;
15(9):
1055 - 1061.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H.B. Benedict and F. Fazekas
Benign or not benign MS: A role for routine neuropsychological assessment?
Neurology,
August 18, 2009;
73(7):
494 - 495.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Morrow, B Weinstock-Guttman, F. Munschauer, D Hojnacki, and R. Benedict
Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis
Multiple Sclerosis,
August 1, 2009;
15(8):
998 - 1005.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G Arrondo, M Alegre, J Sepulcre, J Iriarte, J Artieda, and P Villoslada
Abnormalities in brain synchronization are correlated with cognitive impairment in multiple sclerosis
Multiple Sclerosis,
April 1, 2009;
15(4):
509 - 516.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F Patti
Cognitive impairment in multiple sclerosis
Multiple Sclerosis,
January 1, 2009;
15(1):
2 - 8.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B Brochet, M. Deloire, M Bonnet, E Salort-Campana, J. Ouallet, K. Petry, and V Dousset
Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study
Multiple Sclerosis,
November 1, 2008;
14(9):
1242 - 1249.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J Toledo, J Sepulcre, A Salinas-Alaman, A Garcia-Layana, M Murie-Fernandez, B Bejarano, and P Villoslada
Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis
Multiple Sclerosis,
August 1, 2008;
14(7):
906 - 912.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Ghaffar and A. Feinstein
Multiple sclerosis and cannabis: A cognitive and psychiatric study
Neurology,
July 15, 2008;
71(3):
164 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|